Michal Inbar‐Feigenberg

Also affiliated with Hospital for Sick Children

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study”.

Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study

Molecular Genetics and Metabolism(2022)10.1016/j.ymgme.2022.07.017

N/A

0.978DataRank · unranked

49 citations

Barbara K. Burton, Paul Harmatz, Luis González Gutiérrez-Solana, Matilde Ruíz-Garcìa, Simon Jones +9 more

Long-term open-label extension study of the safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II

Molecular Genetics and Metabolism(2022)10.1016/j.ymgme.2022.07.016

N/A

0.631DataRank · unranked

26 citations

Barbara K. Burton, Paul Harmatz, Luis González Gutiérrez-Solana, Matilde Ruíz-Garcìa, Simon Jones +9 more

Clinical features, functional consequences, and rescue pharmacology of missense GRID1 and GRID2 human variants

Human Molecular Genetics(2023)10.1093/hmg/ddad188

N/A

0DataRank · unranked

13 citations

Kathryn B. Garber, Riley E. Perszyk, Cara T Khayat, Steven A. Kell, Maki Kaneko +22 more